Laddar...
Demonstrating Value for Biosimilars: A Conceptual Framework
BACKGROUND: The value proposition for biosimilars can be characterized as a concept that moves beyond the argument of cost reduction relative to the innovator biologic drug and into a framework that incorporates the diverse needs of key healthcare stakeholders during the transition from clinical dev...
Sparad:
I publikationen: | Am Health Drug Benefits |
---|---|
Huvudupphovsmän: | , , , , , , |
Materialtyp: | Artigo |
Språk: | Inglês |
Publicerad: |
Engage Healthcare Communications, LLC
2015
|
Ämnen: | |
Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4467014/ https://ncbi.nlm.nih.gov/pubmed/26085901 |
Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|